|
Drugs: gastrointestinal system
Citations 1-10 of 383 total displayed.
|
Most recent content
(1 Nov 2006):
|
- Inflammatory bowel disease
Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress
- M Zareie, K Johnson-Henry, J Jury, P-C Yang, B-Y Ngan, D M McKay, J D Soderholm, M H Perdue, and P M Sherman
Gut 2006 55: 1553 -1560; published online before print as 10.1136/gut.2005.080739
[Abstract]
[Full text]
- Inflammatory bowel disease
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
- G Van Assche, W J Sandborn, B G Feagan, B A Salzberg, D Silvers, P S Monroe, W M Pandak, F H Anderson, J F Valentine, G E Wild, D J Geenen, R Sprague, S R Targan, P Rutgeerts, V Vexler, D Young, and R S Shames
Gut 2006 55: 1568 -1574; published online before print as 10.1136/gut.2005.089854
[Abstract]
[Full text]
[ Competing interests ]
- Hepatitis
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy
- M Sherman, E M Yoshida, M Deschenes, M Krajden, V G Bain, K Peltekian, F Anderson, K Kaita, S Simonyi, R Balshaw, S S Lee the Canadian Pegasys Study Group
Gut 2006 55: 1631 -1638; published online before print as 10.1136/gut.2005.083113
[Abstract]
[Full text]
[ Competing interests ]
- Letters
A pilot study in patients with established advanced liver fibrosis using pirfenidone
- J Armendáriz-Borunda, M C Islas-Carbajal, E Meza-García, A R Rincón, S Lucano, A S Sandoval, A Salazar, J Berumen, A Alvarez, A Covarrubias, G Aréchiga, and L García
Gut 2006; 55: 1663-1665.
[Extract]
[Full text]
[ web only figure ]
- Letters
Anti-TNF- for treatment of amyloidosis associated with Crohn’s disease • Author’s reply
- A Fernández-Nebro, I Ureña, M V Irigoyen, R García-Vicuña, S Konno, M Iizuka, Y Horie, H Itou, K Shindo, and S Watanabe
Gut 2006; 55: 1666-1667.
[Extract]
[Full text]
[ Competing interests ]
- Letters
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
- B Iacopetta and T Watanabe
Gut 2006; 55: 1671-1672.
[Extract]
[Full text]
- Letters
A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon -2b and ribavirin
- T Watanabe, M Inoue, K Harada, N Homma, M Uchida, N Ogata, R Funada, K Hasegawa, K Soga, and K Shibasaki
Gut 2006; 55: 1682-1683.
[Extract]
[Full text]
|
Past content
(since Mar 1999):
|
- Leading articles
Endocannabinoid overactivity and intestinal inflammation
- V Di Marzo and A A Izzo
Gut 2006; 55: 1373-1376.
[Abstract]
[Full text]
- Commentaries
Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
- J P Galmiche
Gut 2006; 55: 1379-1381.
[Extract]
[Full text]
- Oesophagus
Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring
- I Mainie, R Tutuian, S Shay, M Vela, X Zhang, D Sifrim, and D O Castell
Gut 2006 55: 1398 -1402; published online before print as 10.1136/gut.2005.087668
[Abstract]
[Full text]
|
|
